Auris Medical Holding AG Provides Update on Clinical Development Plan for AM-111
04 mai 2015 08h30 HE
|
Auris Medical AG
Zug, Switzerland, May 4, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
Auris Medical Announces Publications Related to AM-101 in Peer-Reviewed Scientific and Medical Journals
20 avr. 2015 16h01 HE
|
Auris Medical AG
Zug, Switzerland, April 20, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical to Propose Election of Two New Board Members at Forthcoming Annual General Meeting
30 mars 2015 18h03 HE
|
Auris Medical AG
Zug, Switzerland, March 30, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedi-cated to developing therapeutics that address important unmet medical needs in...
Auris Medical Holding AG Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update
19 mars 2015 07h00 HE
|
Auris Medical AG
Zug, Switzerland, March 19, 2015 - Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the fourth quarter and financial...
Auris Medical to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Thursday, March 19, 2015
16 mars 2015 08h46 HE
|
Auris Medical AG
ZUG, Switzerland, March 16, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (Nasdaq:EARS) today announced that it will release its financial results for the fourth quarter and full year 2014, on...
Auris Medical Q4 and FY 2014 Earnings Release Announcement
16 mars 2015 08h38 HE
|
Auris Medical AG
Auris Medical AG: Auris Medical to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Thursday, March 19, 2015 Zug, Switzerland, March 16, 2015 - Auris Medical...
Auris Medical Announces Recently Granted Patent in India for the Treatment of Tinnitus
13 mars 2015 07h00 HE
|
Auris Medical AG
Zug, Switzerland, March 13, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical to Host Key Opinion Leader Meeting on Tinnitus Treatments on March 13 in New York City
11 mars 2015 07h00 HE
|
Auris Medical AG
Zug, Switzerland, March 11, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical Announces Completion of Interim Analysis in Post-Acute Tinnitus Stratum of TACTT3 Trial with AM-101
10 mars 2015 08h20 HE
|
Auris Medical AG
Zug, Switzerland, March 10, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical Announces Recently Granted Patent in China for the Treatment of Tinnitus
11 févr. 2015 06h03 HE
|
Auris Medical AG
Zug, Switzerland, February 11, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...